Skip to main content

Table 1 Differences between the two guidelines

From: New avenues of sepsis research: obtaining perspective by analyzing and comparing SSCG 2021 and J-SSCG 2020

 

J-SSCG2020

SSCG2021

Target audience

Medical professionals

Medical professionals and policymakers

Evidence to decision table

8 Domains

12 Domains

Categories of clinical question

BQ, GPS, GRADE, EC

BPS, GRADE, EC

Number of recommendations

125

93

 Definition and diagnosis of sepsis

2

Appendix

 Diagnosis of infection

5

1

 Source control

9

2

 Antimicrobial therapy

11

18

 Intravenous immunoglobulin therapy

3

1

 Initial resuscitation/inotropes

15

20

 Corticosteroid therapy

3

1

 Blood transfusion therapy

4

1

 Respiratory management

6

12

 Management of pain, agitation, and delirium

6

0

 Acute kidney injury/blood purification

7

4

 Nutrition support therapy

10

2

 Blood glucose management

2

1

 Body temperature control

2

0

 Diagnosis and treatment of DIC

6

0

 Venous thromboembolism countermeasures

3

3

 ICU-AW and early rehabilitation

3

0

 Pediatric considerations

13

0

 Neuro intensive care

1

0

 Patients-and family-centered care

7

0

 Sepsis treatment system

5

4

 Stress ulcer prophylaxis

2

1

 Bicarbonate therapy

0

2

 Long-term outcomes and goals of care

0

20

  1. J-SSCG Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock, SSCG Surviving Sepsis Campaign Guideline, BQ background question, GPS good practice statement, GRADE Grading of Recommendations, Assessment, Development and Evaluation, EC expert consensus, BPS best practice statement, DIC disseminated intravascular coagulation, ICU-AW intensive care unit-acquired weakness